S
NEXI

SignatureFD’s NexImmune, Inc. Common Stock NEXI Stock Holding History

SignatureFD’s Portfolio NEXI Stock Details NEXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1
Closed – – 3311
2021
Q3 		$0 Buy
+1
New +$335 ﹤0.01% 3251

Other funds holding NEXI

ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AO
Allen Operations New York $670M AUM 26.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BM
Bridger Management New York $128M AUM 9.54% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

SignatureFD's NEXI Position: Q4 2021 in Review

SignatureFD sold out of NexImmune, Inc. Common Stock (NEXI) in Q4 2021, closing a stake of 1 share.

SignatureFD first reported a position in NEXI in Q3 2021 and held it in 1 quarter. The position peaked at $0 in Q3 2021. 46 funds tracked by Wall St. Rank hold NEXI as of Q4 2021.

  • SignatureFD reported no remaining NexImmune, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • SignatureFD sold 1 NexImmune, Inc. Common Stock share in Q4 2021.
  • SignatureFD first reported a position in NexImmune, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • SignatureFD's NexImmune, Inc. Common Stock position peaked at $0 in Q3 2021.
  • 46 funds tracked by Wall St. Rank held NexImmune, Inc. Common Stock as of Q4 2021.

Based on SignatureFD's 13F filing for Q4 2021, filed 25 Jan 2022.